Inventor · disambiguated record
Emmanuelle Di Tomaso
Also filed as: DI TOMASO EMMANUELLE
3 granted patents·9 pending applications·1 citations·filing 2012–2020
52Inventor score
Files withNOVARTIS AG7HIRAWAT SAMIT2DI TOMASO EMMANUELLE1FRITSCH CHRISTINE1SYROS PHARMACEUTICALS INC1
Top patents by PatentIndex Score
12 records- 0162US9675595B2Synergistic combinations of PI3K- and MEK-inhibitorsFRITSCH CHRISTINE·Filed 2012·Granted Jun 13, 2017·1 cites·2 claims
- 0260US2021196696A1Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitorNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0354US2020138824A1Treatment of cancer with a pi3k inhibitor in a patient preselected for having a pik3ca mutation in the ctdnaNOVARTIS AG·Filed 2019·Application pending·0 cites
- 0453US10434092B2Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitorNOVARTIS AG·Filed 2017·Granted Oct 8, 2019·0 cites·5 claims
- 0553US2020069670A1Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitorNOVARTIS AG·Filed 2019·Application pending·0 cites
- 0648US2017000778A1Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitorDI TOMASO EMMANUELLE·Filed 2014·Application pending·0 cites
- 0747US9913846B2Combination of a PI3 kinase inhibitor with pacitaxel for use in the treatment or prevention of a cancer of the head and neckNOVARTIS AG·Filed 2017·Granted Mar 13, 2018·0 cites·3 claims
- 0845US2016082012A1Combination of a PI3 Kinase Inhibitor with Pacitaxel for Use in the Treatment or Prevention of a Cancer of the Head and NeckHIRAWAT SAMIT·Filed 2014·Application pending·0 cites
- 0939US2016129003A1Pharmaceutical CombinationsHIRAWAT SAMIT·Filed 2014·Application pending·0 cites
- 1037US2018280370A1Dosage regimen for a phosphatidylinositol 3-kinase inhibitorNOVARTIS AG·Filed 2016·Application pending·0 cites
- 1137US2018353515A1Treatment of cancer with a pi3k inhibitor in a patient presselected for having a pik3ca mutation in the ctdnaNOVARTIS AG·Filed 2016·Application pending·0 cites
- 1225US2020113902A1Compositions and methods for treating cancers with covalent inhibitors of cyclin-dependent kinase 7 (cdk7)SYROS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Emmanuelle Di Tomaso files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →